Paul TheisenPatient Acquisition
Daniel SontupeMarket Access
David LinetskyPoint-of-Care Marketing
Liz KaneImpactful Strategy
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Brenda SnowAuthentic Patient Voice
Joey CohenMedication Adherence
Frank BurrellScientific Storytelling
Bud BilanichSuccess Coach
Matthew DurhamOmnidynamic Marketing
Pat PurcellMeeting Engagement
Suma Ramadas, PhDMedical Affairs
Matt TurnerPatient Affordability
Ad-RTS-hIL-12 plus 20mg veledimex (Controlled IL-12) determined to be preferred dosing with low-dose steroids ...
New Data from Pivotal Phase 3 Study Investigating Lanadelumab as a Prophylactic Treatment for ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email